nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanidine—KCND2—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0125	0.0171	CbGpPWpGaD
Guanidine—KCNA7—tendon—bone cancer	0.0121	0.068	CbGeAlD
Guanidine—KCNH7—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0109	0.015	CbGpPWpGaD
Guanidine—DLG4—CREB phosphorylation through the activation of Ras—BRAF—bone cancer	0.0106	0.0145	CbGpPWpGaD
Guanidine—KCNB1—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	0.0105	0.0144	CbGpPWpGaD
Guanidine—KCNC2—Regulation of insulin secretion—GNA11—bone cancer	0.0105	0.0144	CbGpPWpGaD
Guanidine—KCNS3—Regulation of insulin secretion—GNA11—bone cancer	0.0105	0.0144	CbGpPWpGaD
Guanidine—KCNG2—Regulation of insulin secretion—GNA11—bone cancer	0.0105	0.0144	CbGpPWpGaD
Guanidine—KCNB1—Regulation of insulin secretion—GNA11—bone cancer	0.00997	0.0136	CbGpPWpGaD
Guanidine—KCNA3—BDNF signaling pathway—EIF2S1—bone cancer	0.00914	0.0125	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—FEV—bone cancer	0.00879	0.012	CbGpPWpGaD
Guanidine—DLG4—Post NMDA receptor activation events—BRAF—bone cancer	0.0087	0.0119	CbGpPWpGaD
Guanidine—DLG4—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—bone cancer	0.00862	0.0118	CbGpPWpGaD
Guanidine—KCNG2—Integration of energy metabolism—GNA11—bone cancer	0.00827	0.0113	CbGpPWpGaD
Guanidine—KCNS3—Integration of energy metabolism—GNA11—bone cancer	0.00827	0.0113	CbGpPWpGaD
Guanidine—KCNC2—Integration of energy metabolism—GNA11—bone cancer	0.00827	0.0113	CbGpPWpGaD
Guanidine—ALDH2—Tryptophan metabolism—CYP3A4—bone cancer	0.00804	0.011	CbGpPWpGaD
Guanidine—DLG4—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—bone cancer	0.00801	0.011	CbGpPWpGaD
Guanidine—KCNB1—Integration of energy metabolism—GNA11—bone cancer	0.00784	0.0107	CbGpPWpGaD
Guanidine—DLG4—ErbB4 signaling events—MDM2—bone cancer	0.00762	0.0104	CbGpPWpGaD
Guanidine—KCNH3—spinal cord—bone cancer	0.00751	0.0422	CbGeAlD
Guanidine—KCNH8—spinal cord—bone cancer	0.00728	0.0409	CbGeAlD
Guanidine—KCNA5—connective tissue—bone cancer	0.00722	0.0406	CbGeAlD
Guanidine—KCNA3—spinal cord—bone cancer	0.00687	0.0386	CbGeAlD
Guanidine—DLG4—tendon—bone cancer	0.00678	0.0381	CbGeAlD
Guanidine—DLG4—spinal cord—bone cancer	0.00654	0.0367	CbGeAlD
Guanidine—KCNA2—spinal cord—bone cancer	0.00654	0.0367	CbGeAlD
Guanidine—KCNC4—tendon—bone cancer	0.00648	0.0364	CbGeAlD
Guanidine—KCNQ4—tendon—bone cancer	0.00623	0.035	CbGeAlD
Guanidine—KCNQ5—tendon—bone cancer	0.00606	0.0341	CbGeAlD
Guanidine—KCNC1—spinal cord—bone cancer	0.00601	0.0338	CbGeAlD
Guanidine—KCNB1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00588	0.00804	CbGpPWpGaD
Guanidine—KCNF1—tendon—bone cancer	0.00555	0.0312	CbGeAlD
Guanidine—KCNF1—spinal cord—bone cancer	0.00535	0.0301	CbGeAlD
Guanidine—ALDH2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00527	0.00721	CbGpPWpGaD
Guanidine—KCNH2—Hematopoietic Stem Cell Differentiation—IL3—bone cancer	0.00517	0.00707	CbGpPWpGaD
Guanidine—KCNA5—tendon—bone cancer	0.00497	0.0279	CbGeAlD
Guanidine—KCNS3—tendon—bone cancer	0.00486	0.0273	CbGeAlD
Guanidine—KCNA5—spinal cord—bone cancer	0.00479	0.0269	CbGeAlD
Guanidine—RNASE1—tendon—bone cancer	0.00472	0.0265	CbGeAlD
Guanidine—KCNS3—spinal cord—bone cancer	0.00469	0.0264	CbGeAlD
Guanidine—GAMT—tendon—bone cancer	0.00459	0.0258	CbGeAlD
Guanidine—RNASE1—bone marrow—bone cancer	0.00457	0.0257	CbGeAlD
Guanidine—RNASE1—spinal cord—bone cancer	0.00455	0.0256	CbGeAlD
Guanidine—GAMT—spinal cord—bone cancer	0.00443	0.0249	CbGeAlD
Guanidine—KCND2—Circadian rythm related genes—GNA11—bone cancer	0.00423	0.00579	CbGpPWpGaD
Guanidine—KCND2—Circadian rythm related genes—EZH2—bone cancer	0.00421	0.00577	CbGpPWpGaD
Guanidine—KCND2—spinal cord—bone cancer	0.00409	0.023	CbGeAlD
Guanidine—KCNA1—tendon—bone cancer	0.00371	0.0209	CbGeAlD
Guanidine—KCNH7—Circadian rythm related genes—GNA11—bone cancer	0.0037	0.00506	CbGpPWpGaD
Guanidine—ALDH2—Tryptophan metabolism—MDM2—bone cancer	0.0037	0.00506	CbGpPWpGaD
Guanidine—KCNH7—Circadian rythm related genes—EZH2—bone cancer	0.00368	0.00504	CbGpPWpGaD
Guanidine—ALDH2—connective tissue—bone cancer	0.00363	0.0204	CbGeAlD
Guanidine—KCNA1—spinal cord—bone cancer	0.00358	0.0201	CbGeAlD
Guanidine—KCNQ1—bone marrow—bone cancer	0.00347	0.0195	CbGeAlD
Guanidine—GAMT—Metabolism—NDUFA12—bone cancer	0.00344	0.0047	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—NDUFA12—bone cancer	0.003	0.00411	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—NDUFA12—bone cancer	0.003	0.00411	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—NDUFA12—bone cancer	0.003	0.00411	CbGpPWpGaD
Guanidine—DLG4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.003	0.0041	CbGpPWpGaD
Guanidine—KCNA3—BDNF signaling pathway—JUN—bone cancer	0.00289	0.00395	CbGpPWpGaD
Guanidine—GAMT—Metabolism—NT5C3A—bone cancer	0.00285	0.0039	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—NDUFA12—bone cancer	0.00285	0.0039	CbGpPWpGaD
Guanidine—Azotaemia—Methotrexate—bone cancer	0.00283	0.0309	CcSEcCtD
Guanidine—ALDH2—Biological oxidations—CYP3A4—bone cancer	0.0028	0.00383	CbGpPWpGaD
Guanidine—Body temperature increased—Carboplatin—bone cancer	0.00264	0.0289	CcSEcCtD
Guanidine—KCNF1—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNS1—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNS2—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNH1—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNG4—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNA10—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNA4—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNA6—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNG3—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCND1—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNC1—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNG1—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNA5—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNA7—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNH8—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNC4—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNB2—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNH3—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNA2—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNC3—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNH4—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNV1—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNH5—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—KCNV2—Neuronal System—BRAF—bone cancer	0.00262	0.00359	CbGpPWpGaD
Guanidine—SLC22A3—connective tissue—bone cancer	0.00258	0.0145	CbGeAlD
Guanidine—DLG4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00251	0.00344	CbGpPWpGaD
Guanidine—ALDH2—tendon—bone cancer	0.00249	0.014	CbGeAlD
Guanidine—KCNG2—Metabolism—NT5C3A—bone cancer	0.00249	0.00341	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—NT5C3A—bone cancer	0.00249	0.00341	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—NT5C3A—bone cancer	0.00249	0.00341	CbGpPWpGaD
Guanidine—Eruption—Methotrexate—bone cancer	0.00245	0.0268	CcSEcCtD
Guanidine—ALDH2—bone marrow—bone cancer	0.00242	0.0136	CbGeAlD
Guanidine—ALDH2—spinal cord—bone cancer	0.00241	0.0135	CbGeAlD
Guanidine—Folliculitis—Methotrexate—bone cancer	0.0024	0.0262	CcSEcCtD
Guanidine—ALDH2—Biological oxidations—GSTP1—bone cancer	0.0024	0.00328	CbGpPWpGaD
Guanidine—KCND2—Circadian rythm related genes—CDK4—bone cancer	0.00238	0.00325	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—NT5C3A—bone cancer	0.00236	0.00323	CbGpPWpGaD
Guanidine—KCNA3—Neuronal System—BRAF—bone cancer	0.00234	0.0032	CbGpPWpGaD
Guanidine—DLG4—L1CAM interactions—EGFR—bone cancer	0.00232	0.00318	CbGpPWpGaD
Guanidine—Eruption—Epirubicin—bone cancer	0.00229	0.0251	CcSEcCtD
Guanidine—DLG4—Transmission across Chemical Synapses—BRAF—bone cancer	0.00225	0.00309	CbGpPWpGaD
Guanidine—Folliculitis—Epirubicin—bone cancer	0.00224	0.0245	CcSEcCtD
Guanidine—KCNQ4—Neuronal System—BRAF—bone cancer	0.00223	0.00305	CbGpPWpGaD
Guanidine—KCNQ5—Neuronal System—BRAF—bone cancer	0.00223	0.00305	CbGpPWpGaD
Guanidine—KCNG1—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNH5—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNC4—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNA5—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNS1—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCND1—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNC1—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNA6—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNG3—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNH4—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNV1—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNH1—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNF1—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNC3—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNA2—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNH3—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNB2—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNG4—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNA7—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNV2—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNS2—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNA10—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNA4—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—KCNH8—Neuronal System—MDM2—bone cancer	0.0022	0.003	CbGpPWpGaD
Guanidine—Eruption—Doxorubicin—bone cancer	0.00212	0.0232	CcSEcCtD
Guanidine—KCNH7—Circadian rythm related genes—CDK4—bone cancer	0.00208	0.00285	CbGpPWpGaD
Guanidine—Folliculitis—Doxorubicin—bone cancer	0.00207	0.0227	CcSEcCtD
Guanidine—KCNA3—Neuronal System—MDM2—bone cancer	0.00196	0.00268	CbGpPWpGaD
Guanidine—SLC22A4—tendon—bone cancer	0.00195	0.0109	CbGeAlD
Guanidine—Irritability—Cisplatin—bone cancer	0.0019	0.0208	CcSEcCtD
Guanidine—DLG4—Transmission across Chemical Synapses—MDM2—bone cancer	0.00189	0.00259	CbGpPWpGaD
Guanidine—SLC22A4—bone marrow—bone cancer	0.00189	0.0106	CbGeAlD
Guanidine—SLC22A4—spinal cord—bone cancer	0.00188	0.0106	CbGeAlD
Guanidine—KCNQ1—SIDS Susceptibility Pathways—JUN—bone cancer	0.00188	0.00257	CbGpPWpGaD
Guanidine—KCNS3—Neuronal System—BRAF—bone cancer	0.00187	0.00256	CbGpPWpGaD
Guanidine—KCNC2—Neuronal System—BRAF—bone cancer	0.00187	0.00256	CbGpPWpGaD
Guanidine—KCNG2—Neuronal System—BRAF—bone cancer	0.00187	0.00256	CbGpPWpGaD
Guanidine—KCNQ4—Neuronal System—MDM2—bone cancer	0.00187	0.00255	CbGpPWpGaD
Guanidine—KCNQ5—Neuronal System—MDM2—bone cancer	0.00187	0.00255	CbGpPWpGaD
Guanidine—Petechiae—Methotrexate—bone cancer	0.00183	0.02	CcSEcCtD
Guanidine—KCND3—Neuronal System—BRAF—bone cancer	0.00182	0.00249	CbGpPWpGaD
Guanidine—KCNB1—Neuronal System—BRAF—bone cancer	0.00177	0.00242	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—MET—bone cancer	0.00173	0.00237	CbGpPWpGaD
Guanidine—DLG4—Neuronal System—BRAF—bone cancer	0.00173	0.00236	CbGpPWpGaD
Guanidine—Petechiae—Epirubicin—bone cancer	0.00171	0.0187	CcSEcCtD
Guanidine—ALDH2—Metabolism—NDUFA12—bone cancer	0.00168	0.0023	CbGpPWpGaD
Guanidine—SLC22A4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00163	0.00223	CbGpPWpGaD
Guanidine—KCNQ1—Neuronal System—BRAF—bone cancer	0.00162	0.00222	CbGpPWpGaD
Guanidine—KCND2—Neuronal System—BRAF—bone cancer	0.00162	0.00222	CbGpPWpGaD
Guanidine—KCNQ2—L1CAM interactions—EGFR—bone cancer	0.00162	0.00221	CbGpPWpGaD
Guanidine—KCNQ3—L1CAM interactions—EGFR—bone cancer	0.00162	0.00221	CbGpPWpGaD
Guanidine—KCNH6—Neuronal System—BRAF—bone cancer	0.00159	0.00217	CbGpPWpGaD
Guanidine—Petechiae—Doxorubicin—bone cancer	0.00158	0.0173	CcSEcCtD
Guanidine—KCNS3—Neuronal System—MDM2—bone cancer	0.00156	0.00214	CbGpPWpGaD
Guanidine—KCNG2—Neuronal System—MDM2—bone cancer	0.00156	0.00214	CbGpPWpGaD
Guanidine—KCNC2—Neuronal System—MDM2—bone cancer	0.00156	0.00214	CbGpPWpGaD
Guanidine—KCND2—Circadian rythm related genes—JUN—bone cancer	0.00153	0.0021	CbGpPWpGaD
Guanidine—KCND3—Neuronal System—MDM2—bone cancer	0.00152	0.00208	CbGpPWpGaD
Guanidine—KCNB1—Neuronal System—MDM2—bone cancer	0.00148	0.00203	CbGpPWpGaD
Guanidine—DLG4—Neuronal System—MDM2—bone cancer	0.00145	0.00198	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—MMP2—bone cancer	0.00145	0.00198	CbGpPWpGaD
Guanidine—KCNA1—Neuronal System—BRAF—bone cancer	0.00144	0.00196	CbGpPWpGaD
Guanidine—KCNH7—Neuronal System—BRAF—bone cancer	0.00142	0.00194	CbGpPWpGaD
Guanidine—SLC22A4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.0014	0.00192	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—NT5C3A—bone cancer	0.00139	0.0019	CbGpPWpGaD
Guanidine—ALDH2—Transmission across Chemical Synapses—BRAF—bone cancer	0.00136	0.00186	CbGpPWpGaD
Guanidine—Ecchymosis—Methotrexate—bone cancer	0.00136	0.0149	CcSEcCtD
Guanidine—KCNQ1—Neuronal System—MDM2—bone cancer	0.00136	0.00186	CbGpPWpGaD
Guanidine—KCND2—Neuronal System—MDM2—bone cancer	0.00136	0.00186	CbGpPWpGaD
Guanidine—KCNH7—Circadian rythm related genes—JUN—bone cancer	0.00134	0.00183	CbGpPWpGaD
Guanidine—KCNH6—Neuronal System—MDM2—bone cancer	0.00133	0.00182	CbGpPWpGaD
Guanidine—KCNH2—bone marrow—bone cancer	0.00132	0.00743	CbGeAlD
Guanidine—KCNH2—spinal cord—bone cancer	0.00132	0.00739	CbGeAlD
Guanidine—SLC22A5—tendon—bone cancer	0.00129	0.00725	CbGeAlD
Guanidine—Flushing—Cisplatin—bone cancer	0.00128	0.014	CcSEcCtD
Guanidine—Ecchymosis—Epirubicin—bone cancer	0.00127	0.0139	CcSEcCtD
Guanidine—GAMT—Metabolism—ENO2—bone cancer	0.00125	0.00171	CbGpPWpGaD
Guanidine—SLC22A5—spinal cord—bone cancer	0.00124	0.00699	CbGeAlD
Guanidine—DLG4—Developmental Biology—CDK4—bone cancer	0.00124	0.00169	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—MET—bone cancer	0.00124	0.00169	CbGpPWpGaD
Guanidine—SLC22A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00123	0.00168	CbGpPWpGaD
Guanidine—SLC22A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00122	0.00167	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—MET—bone cancer	0.00121	0.00165	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—MET—bone cancer	0.00121	0.00165	CbGpPWpGaD
Guanidine—KCNQ2—Neuronal System—BRAF—bone cancer	0.0012	0.00165	CbGpPWpGaD
Guanidine—KCNQ3—Neuronal System—BRAF—bone cancer	0.0012	0.00165	CbGpPWpGaD
Guanidine—KCNA1—Neuronal System—MDM2—bone cancer	0.0012	0.00165	CbGpPWpGaD
Guanidine—KCNH7—Neuronal System—MDM2—bone cancer	0.00119	0.00162	CbGpPWpGaD
Guanidine—Ecchymosis—Doxorubicin—bone cancer	0.00118	0.0129	CcSEcCtD
Guanidine—GAMT—Metabolism—DHFR—bone cancer	0.00116	0.00158	CbGpPWpGaD
Guanidine—Vascular purpura—Epirubicin—bone cancer	0.00114	0.0125	CcSEcCtD
Guanidine—ALDH2—Transmission across Chemical Synapses—MDM2—bone cancer	0.00114	0.00156	CbGpPWpGaD
Guanidine—Tremor—Cisplatin—bone cancer	0.00112	0.0123	CcSEcCtD
Guanidine—Anaemia—Cisplatin—bone cancer	0.00111	0.0121	CcSEcCtD
Guanidine—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00111	0.00151	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—ENO2—bone cancer	0.00109	0.00149	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—ENO2—bone cancer	0.00109	0.00149	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—ENO2—bone cancer	0.00109	0.00149	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—MMP9—bone cancer	0.00109	0.00149	CbGpPWpGaD
Guanidine—GAMT—Metabolism—GNA11—bone cancer	0.00108	0.00148	CbGpPWpGaD
Guanidine—Leukopenia—Cisplatin—bone cancer	0.00107	0.0118	CcSEcCtD
Guanidine—Purpura—Epirubicin—bone cancer	0.00106	0.0116	CcSEcCtD
Guanidine—SLC22A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00106	0.00145	CbGpPWpGaD
Guanidine—Vascular purpura—Doxorubicin—bone cancer	0.00106	0.0116	CcSEcCtD
Guanidine—SLC22A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00106	0.00144	CbGpPWpGaD
Guanidine—ALDH2—Neuronal System—BRAF—bone cancer	0.00104	0.00143	CbGpPWpGaD
Guanidine—Irritability—Methotrexate—bone cancer	0.00104	0.0114	CcSEcCtD
Guanidine—Mood swings—Methotrexate—bone cancer	0.00104	0.0113	CcSEcCtD
Guanidine—KCNB1—Metabolism—ENO2—bone cancer	0.00103	0.00141	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—MMP2—bone cancer	0.00103	0.00141	CbGpPWpGaD
Guanidine—Ataxia—Methotrexate—bone cancer	0.00103	0.0113	CcSEcCtD
Guanidine—KCND2—Circadian rythm related genes—TP53—bone cancer	0.00101	0.00138	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—DHFR—bone cancer	0.00101	0.00138	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—DHFR—bone cancer	0.00101	0.00138	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—DHFR—bone cancer	0.00101	0.00138	CbGpPWpGaD
Guanidine—Liver function test abnormal—Methotrexate—bone cancer	0.00101	0.011	CcSEcCtD
Guanidine—KCNQ3—Neuronal System—MDM2—bone cancer	0.00101	0.00138	CbGpPWpGaD
Guanidine—KCNQ2—Neuronal System—MDM2—bone cancer	0.00101	0.00138	CbGpPWpGaD
Guanidine—Affect lability—Epirubicin—bone cancer	0.00101	0.011	CcSEcCtD
Guanidine—KCNQ3—Axon guidance—MMP2—bone cancer	0.00101	0.00138	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—MMP2—bone cancer	0.00101	0.00138	CbGpPWpGaD
Guanidine—Purpura—Doxorubicin—bone cancer	0.000982	0.0107	CcSEcCtD
Guanidine—GAMT—Metabolism—CYP3A4—bone cancer	0.000981	0.00134	CbGpPWpGaD
Guanidine—Mood swings—Epirubicin—bone cancer	0.000969	0.0106	CcSEcCtD
Guanidine—Ataxia—Epirubicin—bone cancer	0.000962	0.0105	CcSEcCtD
Guanidine—SLC22A3—Metabolism—NDUFA12—bone cancer	0.000959	0.00131	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—DHFR—bone cancer	0.000959	0.00131	CbGpPWpGaD
Guanidine—Thrombocytopenia—Cisplatin—bone cancer	0.000958	0.0105	CcSEcCtD
Guanidine—Tachycardia—Cisplatin—bone cancer	0.000955	0.0105	CcSEcCtD
Guanidine—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000955	0.00131	CbGpPWpGaD
Guanidine—Hyperhidrosis—Cisplatin—bone cancer	0.000946	0.0104	CcSEcCtD
Guanidine—KCNC2—Metabolism—GNA11—bone cancer	0.000945	0.00129	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—GNA11—bone cancer	0.000945	0.00129	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—GNA11—bone cancer	0.000945	0.00129	CbGpPWpGaD
Guanidine—Liver function test abnormal—Epirubicin—bone cancer	0.000944	0.0103	CcSEcCtD
Guanidine—Anorexia—Cisplatin—bone cancer	0.000933	0.0102	CcSEcCtD
Guanidine—Affect lability—Doxorubicin—bone cancer	0.000931	0.0102	CcSEcCtD
Guanidine—Hypotension—Cisplatin—bone cancer	0.000915	0.01	CcSEcCtD
Guanidine—Mood swings—Doxorubicin—bone cancer	0.000896	0.00981	CcSEcCtD
Guanidine—KCNB1—Metabolism—GNA11—bone cancer	0.000896	0.00123	CbGpPWpGaD
Guanidine—Ataxia—Doxorubicin—bone cancer	0.00089	0.00974	CcSEcCtD
Guanidine—KCNH7—Circadian rythm related genes—TP53—bone cancer	0.000884	0.00121	CbGpPWpGaD
Guanidine—Paraesthesia—Cisplatin—bone cancer	0.000879	0.00962	CcSEcCtD
Guanidine—DLG4—Axon guidance—EGFR—bone cancer	0.000878	0.0012	CbGpPWpGaD
Guanidine—ALDH2—Neuronal System—MDM2—bone cancer	0.000874	0.0012	CbGpPWpGaD
Guanidine—Liver function test abnormal—Doxorubicin—bone cancer	0.000874	0.00956	CcSEcCtD
Guanidine—KCNQ2—Developmental Biology—CDK4—bone cancer	0.000861	0.00118	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—MET—bone cancer	0.000861	0.00118	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—CDK4—bone cancer	0.000861	0.00118	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—MET—bone cancer	0.000861	0.00118	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—CYP3A4—bone cancer	0.000857	0.00117	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—CYP3A4—bone cancer	0.000857	0.00117	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—CYP3A4—bone cancer	0.000857	0.00117	CbGpPWpGaD
Guanidine—Decreased appetite—Cisplatin—bone cancer	0.000851	0.00932	CcSEcCtD
Guanidine—GAMT—Metabolism—GSTP1—bone cancer	0.000839	0.00115	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—CYP3A4—bone cancer	0.000813	0.00111	CbGpPWpGaD
Guanidine—Sweating—Methotrexate—bone cancer	0.000807	0.00884	CcSEcCtD
Guanidine—Feeling abnormal—Cisplatin—bone cancer	0.000807	0.00883	CcSEcCtD
Guanidine—SLC22A3—Metabolism—NT5C3A—bone cancer	0.000795	0.00109	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—MMP9—bone cancer	0.000775	0.00106	CbGpPWpGaD
Guanidine—Body temperature increased—Cisplatin—bone cancer	0.000774	0.00847	CcSEcCtD
Guanidine—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00077	0.00105	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—MMP9—bone cancer	0.000756	0.00104	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—MMP9—bone cancer	0.000756	0.00104	CbGpPWpGaD
Guanidine—Sweating—Epirubicin—bone cancer	0.000756	0.00827	CcSEcCtD
Guanidine—KCNG2—Metabolism—GSTP1—bone cancer	0.000733	0.001	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—GSTP1—bone cancer	0.000733	0.001	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—GSTP1—bone cancer	0.000733	0.001	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—MMP2—bone cancer	0.000718	0.000983	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—MMP2—bone cancer	0.000718	0.000983	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000717	0.000982	CbGpPWpGaD
Guanidine—Sweating—Doxorubicin—bone cancer	0.000699	0.00765	CcSEcCtD
Guanidine—KCNB1—Metabolism—GSTP1—bone cancer	0.000695	0.000951	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000695	0.000951	CbGpPWpGaD
Guanidine—Diarrhoea—Cisplatin—bone cancer	0.00067	0.00733	CcSEcCtD
Guanidine—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000664	0.000909	CbGpPWpGaD
Guanidine—Flushing—Epirubicin—bone cancer	0.000657	0.00719	CcSEcCtD
Guanidine—DLG4—Developmental Biology—EGFR—bone cancer	0.000626	0.000857	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000619	0.000847	CbGpPWpGaD
Guanidine—Rash—Cisplatin—bone cancer	0.000617	0.00676	CcSEcCtD
Guanidine—Dermatitis—Cisplatin—bone cancer	0.000617	0.00675	CcSEcCtD
Guanidine—KCNQ2—Axon guidance—EGFR—bone cancer	0.000611	0.000836	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—EGFR—bone cancer	0.000611	0.000836	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—ENO2—bone cancer	0.000609	0.000834	CbGpPWpGaD
Guanidine—Anaemia—Methotrexate—bone cancer	0.000608	0.00666	CcSEcCtD
Guanidine—Flushing—Doxorubicin—bone cancer	0.000608	0.00665	CcSEcCtD
Guanidine—Tension—Epirubicin—bone cancer	0.000604	0.00662	CcSEcCtD
Guanidine—SLC22A2—Metabolism—NDUFA12—bone cancer	0.000602	0.000823	CbGpPWpGaD
Guanidine—KCNH2—Neuronal System—BRAF—bone cancer	0.000599	0.00082	CbGpPWpGaD
Guanidine—Nervousness—Epirubicin—bone cancer	0.000598	0.00655	CcSEcCtD
Guanidine—Leukopenia—Methotrexate—bone cancer	0.000589	0.00645	CcSEcCtD
Guanidine—Nausea—Cisplatin—bone cancer	0.000581	0.00637	CcSEcCtD
Guanidine—Anaemia—Epirubicin—bone cancer	0.000569	0.00623	CcSEcCtD
Guanidine—ALDH2—Metabolism—DHFR—bone cancer	0.000565	0.000773	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NDUFA12—bone cancer	0.000561	0.000767	CbGpPWpGaD
Guanidine—Tension—Doxorubicin—bone cancer	0.000559	0.00612	CcSEcCtD
Guanidine—Nervousness—Doxorubicin—bone cancer	0.000553	0.00606	CcSEcCtD
Guanidine—Leukopenia—Epirubicin—bone cancer	0.000551	0.00604	CcSEcCtD
Guanidine—Palpitations—Epirubicin—bone cancer	0.000544	0.00596	CcSEcCtD
Guanidine—Confusional state—Methotrexate—bone cancer	0.000542	0.00593	CcSEcCtD
Guanidine—KCNQ2—Developmental Biology—MMP9—bone cancer	0.00054	0.000739	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—MMP9—bone cancer	0.00054	0.000739	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—GNA11—bone cancer	0.000528	0.000723	CbGpPWpGaD
Guanidine—Anaemia—Doxorubicin—bone cancer	0.000527	0.00577	CcSEcCtD
Guanidine—Thrombocytopenia—Methotrexate—bone cancer	0.000526	0.00576	CcSEcCtD
Guanidine—Hyperhidrosis—Methotrexate—bone cancer	0.000519	0.00568	CcSEcCtD
Guanidine—Dry mouth—Epirubicin—bone cancer	0.000513	0.00561	CcSEcCtD
Guanidine—Anorexia—Methotrexate—bone cancer	0.000512	0.00561	CcSEcCtD
Guanidine—Leukopenia—Doxorubicin—bone cancer	0.00051	0.00558	CcSEcCtD
Guanidine—Confusional state—Epirubicin—bone cancer	0.000507	0.00555	CcSEcCtD
Guanidine—Palpitations—Doxorubicin—bone cancer	0.000504	0.00551	CcSEcCtD
Guanidine—KCNH2—Neuronal System—MDM2—bone cancer	0.000502	0.000687	CbGpPWpGaD
Guanidine—Hypotension—Methotrexate—bone cancer	0.000502	0.00549	CcSEcCtD
Guanidine—SLC22A2—Metabolism—NT5C3A—bone cancer	0.000499	0.000682	CbGpPWpGaD
Guanidine—Thrombocytopenia—Epirubicin—bone cancer	0.000492	0.00539	CcSEcCtD
Guanidine—Tachycardia—Epirubicin—bone cancer	0.000491	0.00537	CcSEcCtD
Guanidine—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000488	0.000668	CbGpPWpGaD
Guanidine—Hyperhidrosis—Epirubicin—bone cancer	0.000486	0.00532	CcSEcCtD
Guanidine—Paraesthesia—Methotrexate—bone cancer	0.000482	0.00528	CcSEcCtD
Guanidine—Anorexia—Epirubicin—bone cancer	0.000479	0.00525	CcSEcCtD
Guanidine—ALDH2—Metabolism—CYP3A4—bone cancer	0.000479	0.000655	CbGpPWpGaD
Guanidine—Dry mouth—Doxorubicin—bone cancer	0.000474	0.00519	CcSEcCtD
Guanidine—Hypotension—Epirubicin—bone cancer	0.00047	0.00514	CcSEcCtD
Guanidine—Confusional state—Doxorubicin—bone cancer	0.000469	0.00513	CcSEcCtD
Guanidine—Decreased appetite—Methotrexate—bone cancer	0.000467	0.00511	CcSEcCtD
Guanidine—SLC22A1—Metabolism—NT5C3A—bone cancer	0.000465	0.000636	CbGpPWpGaD
Guanidine—Thrombocytopenia—Doxorubicin—bone cancer	0.000455	0.00499	CcSEcCtD
Guanidine—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000455	0.000623	CbGpPWpGaD
Guanidine—Tachycardia—Doxorubicin—bone cancer	0.000454	0.00497	CcSEcCtD
Guanidine—Paraesthesia—Epirubicin—bone cancer	0.000451	0.00494	CcSEcCtD
Guanidine—Hyperhidrosis—Doxorubicin—bone cancer	0.00045	0.00492	CcSEcCtD
Guanidine—Anorexia—Doxorubicin—bone cancer	0.000443	0.00485	CcSEcCtD
Guanidine—Feeling abnormal—Methotrexate—bone cancer	0.000443	0.00485	CcSEcCtD
Guanidine—Decreased appetite—Epirubicin—bone cancer	0.000437	0.00478	CcSEcCtD
Guanidine—KCNQ3—Developmental Biology—EGFR—bone cancer	0.000436	0.000597	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—EGFR—bone cancer	0.000436	0.000597	CbGpPWpGaD
Guanidine—Hypotension—Doxorubicin—bone cancer	0.000435	0.00476	CcSEcCtD
Guanidine—GAMT—Metabolism—PTGS2—bone cancer	0.000435	0.000595	CbGpPWpGaD
Guanidine—Abdominal pain—Methotrexate—bone cancer	0.000425	0.00465	CcSEcCtD
Guanidine—Body temperature increased—Methotrexate—bone cancer	0.000425	0.00465	CcSEcCtD
Guanidine—Paraesthesia—Doxorubicin—bone cancer	0.000418	0.00457	CcSEcCtD
Guanidine—Feeling abnormal—Epirubicin—bone cancer	0.000414	0.00453	CcSEcCtD
Guanidine—ALDH2—Metabolism—GSTP1—bone cancer	0.00041	0.000561	CbGpPWpGaD
Guanidine—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000409	0.00056	CbGpPWpGaD
Guanidine—Decreased appetite—Doxorubicin—bone cancer	0.000404	0.00443	CcSEcCtD
Guanidine—Abdominal pain—Epirubicin—bone cancer	0.000397	0.00435	CcSEcCtD
Guanidine—Body temperature increased—Epirubicin—bone cancer	0.000397	0.00435	CcSEcCtD
Guanidine—Feeling abnormal—Doxorubicin—bone cancer	0.000383	0.0042	CcSEcCtD
Guanidine—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000381	0.000522	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PTGS2—bone cancer	0.00038	0.00052	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PTGS2—bone cancer	0.00038	0.00052	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PTGS2—bone cancer	0.00038	0.00052	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—BRAF—bone cancer	0.000374	0.000512	CbGpPWpGaD
Guanidine—Abdominal pain—Doxorubicin—bone cancer	0.000368	0.00403	CcSEcCtD
Guanidine—Body temperature increased—Doxorubicin—bone cancer	0.000368	0.00403	CcSEcCtD
Guanidine—Diarrhoea—Methotrexate—bone cancer	0.000368	0.00402	CcSEcCtD
Guanidine—KCNB1—Metabolism—PTGS2—bone cancer	0.00036	0.000493	CbGpPWpGaD
Guanidine—Dizziness—Methotrexate—bone cancer	0.000355	0.00389	CcSEcCtD
Guanidine—SLC22A1—Neuronal System—BRAF—bone cancer	0.000349	0.000477	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ENO2—bone cancer	0.000348	0.000476	CbGpPWpGaD
Guanidine—Diarrhoea—Epirubicin—bone cancer	0.000344	0.00377	CcSEcCtD
Guanidine—Rash—Methotrexate—bone cancer	0.000339	0.00371	CcSEcCtD
Guanidine—Dermatitis—Methotrexate—bone cancer	0.000338	0.0037	CcSEcCtD
Guanidine—Dizziness—Epirubicin—bone cancer	0.000332	0.00364	CcSEcCtD
Guanidine—SLC22A3—Metabolism—DHFR—bone cancer	0.000323	0.000442	CbGpPWpGaD
Guanidine—Nausea—Methotrexate—bone cancer	0.000319	0.00349	CcSEcCtD
Guanidine—Diarrhoea—Doxorubicin—bone cancer	0.000318	0.00348	CcSEcCtD
Guanidine—Rash—Epirubicin—bone cancer	0.000317	0.00347	CcSEcCtD
Guanidine—Dermatitis—Epirubicin—bone cancer	0.000317	0.00347	CcSEcCtD
Guanidine—SLC22A2—Neuronal System—MDM2—bone cancer	0.000313	0.000429	CbGpPWpGaD
Guanidine—Dizziness—Doxorubicin—bone cancer	0.000308	0.00337	CcSEcCtD
Guanidine—SLC22A3—Metabolism—GNA11—bone cancer	0.000302	0.000413	CbGpPWpGaD
Guanidine—Nausea—Epirubicin—bone cancer	0.000299	0.00327	CcSEcCtD
Guanidine—Rash—Doxorubicin—bone cancer	0.000293	0.00321	CcSEcCtD
Guanidine—Dermatitis—Doxorubicin—bone cancer	0.000293	0.00321	CcSEcCtD
Guanidine—SLC22A1—Neuronal System—MDM2—bone cancer	0.000292	0.0004	CbGpPWpGaD
Guanidine—Nausea—Doxorubicin—bone cancer	0.000276	0.00302	CcSEcCtD
Guanidine—SLC22A3—Metabolism—CYP3A4—bone cancer	0.000274	0.000375	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GSTP1—bone cancer	0.000234	0.00032	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ENO2—bone cancer	0.000218	0.000299	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PTGS2—bone cancer	0.000212	0.00029	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ENO2—bone cancer	0.000204	0.000279	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—DHFR—bone cancer	0.000203	0.000277	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GNA11—bone cancer	0.000189	0.000259	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—DHFR—bone cancer	0.000189	0.000258	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GNA11—bone cancer	0.000176	0.000242	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP3A4—bone cancer	0.000172	0.000235	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP3A4—bone cancer	0.00016	0.000219	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTP1—bone cancer	0.000147	0.000201	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTP1—bone cancer	0.000137	0.000187	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PTGS2—bone cancer	0.000121	0.000166	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PTGS2—bone cancer	7.61e-05	0.000104	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PTGS2—bone cancer	7.09e-05	9.7e-05	CbGpPWpGaD
